Cargando…
P1.12-01 Lung Cancer Screening in the COVID-19 Era: Understanding Program-Level Impact
Autores principales: | Lutzow, L.K., Ciupek, A., Criswell, A., Fine, L., Ma, G.X., King, J.C., Erkmen, C.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452015/ http://dx.doi.org/10.1016/j.jtho.2022.07.185 |
Ejemplares similares
-
P1.12-04 The FLARE score and circulating neutrophils are associated with poor Covid-19 outcomes in patients with thoracic cancers
por: Seguí, E., et al.
Publicado: (2022) -
P1.12-03 Computed Tomography-based Artificial Intelligence System in the Diagnosis of COVID-19
por: Kahya, Y., et al.
Publicado: (2022) -
P1.12-02 The Impact of COVID-19 on Quality of Care for Lung Cancer - Analyses of Prospective Clinical Data from The EnRICH Cohort
por: Brown, B., et al.
Publicado: (2022) -
P1.12-05 Prediction of Clinically Significant Pathological Upstaging in Resected Lung Cancer: Insight from COVID-19 Pandemic (1st wave)
por: Zhang, Y.Z., et al.
Publicado: (2022) -
Développement et validation d’un nomogramme pour prédire l’acceptation de la vaccination contre le SARS-CoV2 chez les patients atteints de cancer
por: Gal, J., et al.
Publicado: (2021)